3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
14
Prostatic Neoplasms
12
Multiple Myeloma
8
Neoplasm Metastasis
6
Osteoporosis
4
Carcinoma, Renal Cell
3
Carcinoma, Non-Small-Cell Lung
3
Ovarian Neoplasms
2
Neoplasms, Plasma Cell
2
Lung Neoplasms
2
Kidney Neoplasms
2
Bone Diseases
2
Uterine Cervical Neoplasms
1
Urologic Neoplasms
1
Triple Negative Breast Neoplasms
1
Small Cell Lung Carcinoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pleural Effusion, Malignant
1
Pancreatic Neoplasms
1
Osteonecrosis
1
Oligodendroglioma
1
Neovascularization, Pathologic
1
Neoplasms by Site
1
Neoplasms
1
Neoplasm, Residual
1
Neoplasm Micrometastasis
1
Nasopharyngeal Neoplasms
1
Myelodysplastic Syndromes
1
Mesothelioma
1
Lymphoma
1
Interventions
Zoledronic Acid
1
Rubidium-82
1
Neoadjuvant Therapy
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Neovascularization, Pathologic
×
Zoledronic Acid
×
Clear all
NCT01367288
2019-05-28
NEOZOL
Hospices Civils de Lyon
Phase 2
Completed
53 enrolled